Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, substance use research
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, substance use research
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, Substance Use Research
Barriers to research resulting from DEA scheduling, Drug research related issues
H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues
H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues
Synthetic Fentanyl related issues
H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues
Monitor Contingency Management, Protocol related issues
Duration: January 8, 2009
to
present
General Issues: Budget/Appropriations , Health Issues , Defense
Spending: about $1,000,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: House of Representatives, U.S. Senate, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Health & Human Services - Dept of (HHS), U.S. Senate,, Natl Institutes of Health (NIH),, Office of Natl Drug Control Policy (NDCP),
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Edward Long PhD Legislative Assistant, Senator Tom Harkin
Edward Long (COP cont.) PhD Legislative Director, Senator Brock Adams
Legislative Director, Senator Tom Harkin
StaffDir, Sen Subcomm on Labor, HHS, Education Approps
Katherine Vanlandingham Legislative Asst/Correspondence Dir, Senator Sam Brownback
LegAsst/CorrespDir, Senator Sam Brownback
Edward Long, PhD Legislative Assistant, Senator Tom Harkin
Edward Long, PhD (COP cont.) Legislative Director, Senator Brock Adams
Legislative Director, Senator Tom Harkin
StaffDir,SenSubcommOnLabor,HHS,Ed Approps
Brian Robinson SrLA/Cnsel,Congresswoman Millender-McDonald
Brian Robinson (COP cont.) LA/Corr,Congresswoman Sheila Jackson Lee
H. Stewart Van Scoyoc n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 19.
Original Filing: 301564499.xml
Lobbying Issues
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, substance use research
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025, Provisions relating to NIH, Substance Use Research
Barriers to research resulting from DEA scheduling, Drug research related issues
H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues
H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues
Synthetic Fentanyl related issues
H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues
Monitor Contingency Management, Protocol related issues
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2023
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 19.
Original Filing: 301529391.xml
Lobbying Issues
H.R.5894/S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5894/S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research
Barriers to research resulting from DEA scheduling, Drug research related issues
H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues
H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues
Synthetic Fentanyl related issues
H.R.4531, Support for Patients and Communities Reauthorization Act, Xylazine related issues
Monitor the following:
Contingency Management, Protocol related issues
Farm Bill 2023, Cannabidiol regulation
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2023
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Oct. 19, 2023.
Original Filing: 301505693.xml
Lobbying Issues
S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research
Barriers to research resulting from DEA scheduling, Drug research related issues
H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues
H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues
Synthetic Fentanyl related issues
Monitor Farm Bill 2023, Cannabidiol regulation
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2023
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 19, 2023.
Original Filing: 301481785.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research
Barriers to research resulting from DEA scheduling, Drug research related issues
H.R.467/S.1141, HALT Fentanyl Act, Drug use research related issues
H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues
Synthetic Fentanyl related issues
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2023
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on April 19, 2023.
Original Filing: 301457763.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Provisions relating to NIH, Substance Use Research
Barriers to research resulting from DEA scheduling, Drug research related issues
H.R.467, HALT Fentanyl Act, Drug use research related issues
H.R.568, Save Americans from the Fentanyl Emergency Act (SAFE) Act, Drug use research related issues
Synthetic Fentanyl related issues
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 19, 2023.
Original Filing: 301432316.xml
Lobbying Issues
Provisions relating to NIH, substance use research, as follows:
H.R.8295//S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023
Public Law 117-328, Consolidated Appropriations Act, FY2023
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Provisions relating to NIH, Substance Use Research
Barriers to research resulting from DEA scheduling, Drug research related issues
Public Law 117-215, Cannabidiol & Marijuana Research Expansion Act, Drug use research related issues
H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act
H.R.2405, Streamlining Research on Controlled Substances Act
H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances
S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
S.4591, Cannabis Administration and Opportunity Act, Drug use research
H.R.6184/S.3336, HALT Fentanyl Act, Drug use research related issues
Public Law 117-328, Consolidated Appropriations Act, FY2023, Provisions related to NIH and Substance use research
Monitor H.R.6946, SAFE Act of 2022, Drug use research related issues
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2022
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on Oct. 19, 2022.
Original Filing: 301409819.xml
Lobbying Issues
H.R.8295//S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Provisions relating to NIH, substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Provisions relating to NIH, Substance Use Research
H.R.2630, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act
Barriers to research resulting from DEA scheduling, Drug research related issues
H.R.8454/S.253, Cannabidiol & Marijuana Research Expansion Act, Drug use research related issues
H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act
H.R.2405, Streamlining Research on Controlled Substances Act
H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances
S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
S.4591, Cannabis Administration and Opportunity Act, Drug use research
H.R.6184/S.3336, HALT Fentanyl Act, Drug use research related issues
H.R.6946, SAFE Act of 2022, Drug use research related issues
Monitor Public Law 117-70, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act, Drug use research related issues
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2022
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 19, 2022.
Original Filing: 301384568.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Provisions relating to NIH, substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Provisions relating to NIH, Substance Use Research
Barriers to research resulting from DEA scheduling, Drug research related issues
S.253, Cannabidiol & Marijuana Research Expansion Act, Drug use research related issues
H.R.5657, Medical Marijuana Research Act, Drug use research related issues
H.R.869/S.289, Research Investment to Spark the Economy Act of 2021 (RISE ACT), Drug use research related issues
H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act
H.R.2405, Streamlining Research on Controlled Substances Act
H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances
S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
S.1006, Amend Controlled Substances Act to list fentanyl-related substances to Schedule I controlled substances
Public Law 117-70, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act, Drug use research related issues
Cannabis Administration and Opportunity Act, Drug use research
H.R.6184/S.3336, HALT Fentanyl Act, Drug use research related issues
H.R.6946, SAFE Act of 2022, Drug use research related issues
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2022
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 19, 2022.
Original Filing: 301362237.xml
Lobbying Issues
Provisions relating to NIH, substance use research, as follows:
H.R.4502/S.3062, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022
Public Law 117-103, Consolidated Appropriations Act, FY2022
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Provisions relating to NIH, substance use research
Departments of Labor, Health and Human Services, and Education, and Related
Agencies Appropriations Act, FY2023
Public Law 117-103, Consolidated Appropriations Act, FY2022
Public Law 117-86, Further Additional Extending Government Funding Act
Barriers to research resulting from DEA scheduling, Drug research related issues
S.253, Cannabidiol & Marijuana Research Expansion Act, Drug use research related issues
H.R.5657, Medical Marijuana Research Act, Drug use research related issues
H.R.869/S.289, Research Investment to Spark the Economy Act of 2021 (RISE ACT), Drug use research related issues
H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act
H.R.2405, Streamlining Research on Controlled Substances Act
H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances
S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
S.1006, Amend Controlled Substances Act to list fentanyl-related substances to Schedule I controlled substances
Public Law 117-70, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act, Drug use research related issues
Cannabis Administration and Opportunity Act, Drug use research
H.R.6184/S.3336, HALT Fentanyl Act, Drug use research related issues
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2021
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 19, 2022.
Original Filing: 301327075.xml
Lobbying Issues
H.R.4502/S.3062, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Provisions relating to NIH, substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Provisions relating to NIH, substance use research
Barriers to research resulting from DEA scheduling, Drug research related issues
S.253, Cannabidiol & Marijuana Research Expansion Act, Drug use research related issues
Medical Marijuana Research Act, Drug use research related issues
H.R.869/S.289, Research Investment to Spark the Economy Act of 2021 (RISE ACT), Drug use research related issues
H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act
H.R.2405, Streamlining Research on Controlled Substances Act
H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances
S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
S.1006, Amend Controlled Substances Act to list fentanyl-related substances to Schedule I controlled substances
Public Law 117-70, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act, Drug use research related issues
Cannabis Administration and Opportunity Act, Drug use research
H.R.6184, HALT Fentanyl Act, Drug use research related issues
S.3336, HALT Fentanyl Act, Drug use research related issues
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on Oct. 19, 2021.
Original Filing: 301305005.xml
Lobbying Issues
H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Provisions relating to NIH, substance use research
P.L.117-43, Extending Government Funding and Delivering Emergency Assistance Act, Provisions relating to substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Provisions relating to NIH, substance use research
Barriers to research resulting from DEA scheduling, Drug research related issues
S.253, Cannabidiol & Marijuana Research Expansion Act, Drug abuse research related issues
Medical Marijuana Research Act, Drug abuse research related issues
H.R.869/S.289, Research Investment to Spark the Economy Act of 2021 (RISE ACT), Drug abuse research related issues
H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act
H.R.2405, Streamlining Research on Controlled Substances Act
H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances
S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
S.1006, Amend Controlled Substances Act to list fentanyl-related substances to Schedule I controlled substances
Public Law 117-12, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act, Drug Abuse research related issues
Cannabis Administration and Opportunity Act, Drug Abuse research
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2021
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 19, 2021.
Original Filing: 301279896.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Provisions relating to NIH, substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Provisions relating to NIH, substance use research
Barriers to research resulting from DEA scheduling, Drug research related issues
S.253, Cannabidiol & Marijuana Research Expansion Act, Drug abuse research related issues
Medical Marijuana Research Act, Drug abuse research related issues
H.R.869/S.289, Research Investment to Spark the Economy Act of 2021 (RISE ACT), Drug abuse research related issues
H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act
H.R.2405, Streamlining Research on Controlled Substances Act
H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances
S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
S.1006, Amend Controlled Substances Act to list fentanyl-related substances to Schedule I controlled substances
Public Law 117-12, Extending Temporary Emergency Scheduling of Fentanyl Analogues Act, Drug Abuse research related issues
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2021
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 19, 2021.
Original Filing: 301255773.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Provisions relating to NIH, substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022, Provisions relating to NIH, substance use research
Barriers to research resulting from DEA scheduling, Drug research related issues
S.253, Cannabidiol & Marijuana Research Expansion Act, Drug abuse research related issues
Medical Marijuana Research Act, Drug abuse research related issues
H.R.869/S.289, Research Investment to Spark the Economy Act of 2021 (RISE ACT), Drug abuse related issues
H.R.1910, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
H.R.2366, Support, Treatment and Overdose Prevention of Fentanyl Act
H.R.2405, Streamlining Research on Controlled Substances Act
H.R.2430, To amend the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act to extend for one year the temporary order for fentanyl-related substances
S.339, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
S.1006, Amend Controlled Substances Act to list fentanyl-related substances to Schedule I controlled substances
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2020
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 19, 2021.
Original Filing: 301234160.xml
Lobbying Issues
Provisions relating to NIH, substance use research as follows:
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021
Public Law 116-260, Consolidated Appropriations Act, 2021, Division H, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research
Public Law 116-260, Consolidated Appropriations Act, 2021, Division H, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, Provisions relating to NIH, substance use research
Barriers to research resulting from DEA scheduling, Drug research related issues
S. 2032, Cannabidiol & Marijuana Research Expansion Act, Drug abuse research related issues
H.R.3797, Medical Marijuana Research Act of 2019, Drug abuse research related issues
Monitor Drug abuse research related issues, as follows:
Stop the Importation and Trafficking of Synthetic Analogues (SITSA)
S.3148, Stopping Overdoses of Fentanyl Analogues Act
H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act
Non Human Primates and Biomedical research
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2020
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on Oct. 19, 2020.
Original Filing: 301214371.xml
Lobbying Issues
Provisions relating to NIH, substance use research as follows:
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021
H.R.8319, Continuing Appropriations, FY2021 and Other Extensions Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research
Barriers to research resulting from DEA scheduling, Drug research related issues
S. 2032, Cannabidiol & Marijuana Research Expansion Act, Drug abuse research related issues
H.R.3797, Medical Marijuana Research Act of 2019, Drug abuse research related issues
Monitor Drug abuse research related issues, as follows:
Stop the Importation and Trafficking of Synthetic Analogues (SITSA)
S.3148, Stopping Overdoses of Fentanyl Analogues Act
H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act
S.2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
H.R.5421, Stopping Illicit Trafficking Act of 2019
Public Law 116-114, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act
Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision
Non Human Primates and Biomedical research
H.R.601, Medical Cannabis Research Act
Coronavirus, Healthcare research related issues
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2020
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 17, 2020.
Original Filing: 301191842.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research
Drug abuse research related issues, as follows:
Stop the Importation and Trafficking of Synthetic Analogues (SITSA)
Barriers to research resulting from DEA scheduling
S.3148, Stopping Overdoses of Fentanyl Analogues Act
H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act
S.2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
H.R.5421, Stopping Illicit Trafficking Act of 2019
Public Law 116-114, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act
Monitor Drug abuse research related issues, as follows:
S. 2032, Cannabidiol & Marijuana Research Expansion Act
H.R.3797, Medical Marijuana Research Act of 2019
Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision
Non Human Primates and Biomedical research
H.R.601, Medical Cannabis Research Act
Coronavirus, Healthcare research related issues
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2020
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 17, 2020.
Original Filing: 301169070.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research
Drug abuse research related issues, as follows:
S. 2032, Cannabidiol & Marijuana Research Expansion Act
Stop the Importation and Trafficking of Synthetic Analogues (SITSA)
H.R.3797, Medical Marijuana Research Act of 2019
Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision
Barriers to research resulting from DEA scheduling
Non Human Primates and Biomedical research
H.R.601, Medical Cannabis Research Act
H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act
S.2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
S.3148, Stopping Overdoses of Fentanyl Analogues Act
Public Law 116-114, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act
H.R.5421, Stopping Illicit Trafficking Act of 2019
Monitor Coronavirus, Healthcare related issues
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2019
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108213.xml
Lobbying Issues
Provisions relating to NIH, substance use research, as follows:
Public Law 116-94, Further Consolidated Appropriations Act, 2020, Division A -- Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020
Public Law 116-59, Continuing Appropriations Act, 2020, and Health Extenders Act of 2019
Public Law 116-69, Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 116-94, Further Consolidated Appropriations Act, 2020, Division A -- Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020, Provisions relating to NIH, substance use research, as follows:
Drug abuse research related issues, as follows:
S. 2032, Cannabidiol & Marijuana Research Expansion Act
Stop the Importation and Trafficking of Synthetic Analogues (SITSA)
H.R.3797, Medical Marijuana Research Act of 2019
Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision
Barriers to research resulting from DEA scheduling
Non Human Primates and Biomedical research
H.R.601, Medical Cannabis Research Act
H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act
S.2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Oct. 18, 2019.
Original Filing: 301069243.xml
Lobbying Issues
Provisions relating to NIH, substance use research, as follows:
H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020
H. Res. 431 -- combined the following four regular appropriations bills, 2020, as reported: (1) Labor-HHS-Education (H.R. 2740), (2) Defense (H.R.2968), (3) State-Foreign Operations (H.R. 2839, as modified by the first rule), and (4) Energy and Water (H.R. 2960)
H.R.4378, Continuing Appropriations Act, 2020, and Health Extenders Act of 2019
Public Law 116-37, Bipartisan Budget Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Provisions relating to NIH, substance use research, as follows:
H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020
H. Res. 431 -- combined the following four regular appropriations bills, 2020, as reported: (1) Labor-HHS-Education (H.R. 2740), (2) Defense (H.R.2968), (3) State-Foreign Operations (H.R. 2839, as modified by the first rule), and (4) Energy and Water (H.R. 2960)
Drug abuse research related issues, as follows:
S. 2032, Cannabidiol & Marijuana Research Expansion Act
Stop the Importation and Trafficking of Synthetic Analogues (SITSA)
H.R.3797, Medical Marijuana Research Act of 2019
Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision
Barriers to research resulting from DEA scheduling
Non Human Primates and Biomedical research
H.R.601, Medical Cannabis Research Act
H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 19, 2019.
Original Filing: 301050104.xml
Lobbying Issues
Provisions relating to NIH, substance use research, as follows:
H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020
H. Res. 431 -- combined the following four regular appropriations bills, 2020, as reported: (1) Labor-HHS-Education (H.R. 2740), (2) Defense (H.R.2968), (3) State-Foreign Operations (H.R. 2839, as modified by the first rule), and (4) Energy and Water (H.R. 2960)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Provisions relating to NIH, substance use research, as follows:
H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020
H. Res. 431 -- combined the following four regular appropriations bills, 2020, as reported: (1) Labor-HHS-Education (H.R. 2740), (2) Defense (H.R.2968), (3) State-Foreign Operations (H.R. 2839, as modified by the first rule), and (4) Energy and Water (H.R. 2960)
Drug abuse research related issues, as follows:
S. 2032, Cannabidiol & Marijuana Research Expansion Act
Stop the Importation and Trafficking of Synthetic Analogues (SITSA)
Medical Marijuana Research Act
Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision
Barriers to research resulting from DEA scheduling
Non Human Primates and Biomedical research
H.R.601, Medical Cannabis Research Act
H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2019
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 19, 2019.
Original Filing: 301030255.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020, Provisions relating to NIH, and drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020, Provisions relating to NIH, and drug abuse and treatment
Drug abuse research and treatment related issues:
Cannabidiol & Marijuana Research Expansion Act
Stop the Importation and Trafficking of Synthetic Analogues (SITSA)
Medical Marijuana Research Act
Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision
Barriers to research resulting from DEA scheduling
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2018
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 18, 2019.
Original Filing: 301009174.xml
Lobbying Issues
Public Law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH, and drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH, and drug abuse and treatment
Drug abuse research and treatment related issues:
H.R.1732, Synthetic Drug Control Act of 2017
H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA)
H.R.3391, Medical Marijuana Research Act of 2017
H.R.4825/S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017
S.2260, Opioids and STOP Pain Initiative Act
S.2004, Combating the Opioid Epidemic Act
H.R.5298, Modernizing Drug Enforcement Act of 2018
Public Law 115-271, SUPPORT for Patients and Communities Act
S.1276, Cannabidiol Research Expansion Act
H.R.5634, Medical Cannabis Research Act of 2018
Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2018
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on Oct. 19, 2018.
Original Filing: 300991902.xml
Lobbying Issues
H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH, and drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH, and drug abuse and treatment
Drug abuse research and treatment related issues:
H.R.1732, Synthetic Drug Control Act of 2017
H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA)
H.R.3391, Medical Marijuana Research Act of 2017
S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017
S.2260, Opioids and STOP Pain Initiative Act
S.2004, Combating the Opioid Epidemic Act
H.R.5298, Modernizing Drug Enforcement Act of 2018
H.R.5311/S.2456, Comprehensive Addiction and Recovery Act or CARA 2.0 Act of 2018
H.R.6, SUPPORT for Patients and Communities Act
S.1276, Cannabidiol Research Expansion Act
Marijuana and Cannabidiol Research Expansion Act
H.R.5634, Medical Cannabis Research Act of 2018
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2018
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 19, 2018.
Original Filing: 300969768.xml
Lobbying Issues
Provisions relating to NIH, and drug abuse and treatment, as follows:
S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019, provisions relating to NIH and drug abuse and treatment
Drug abuse research and treatment related issues:
H.R.1732, Synthetic Drug Control Act of 2017
H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA)
H.R.3391, Medical Marijuana Research Act of 2017
S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017
S.2260, Opioids and STOP Pain Initiative Act
S.2004, Combating the Opioid Epidemic Act
H.R.5298, Modernizing Drug Enforcement Act of 2018
H.R.5311/S.2456, Comprehensive Addiction and Recovery Act or CARA 2.0 Act of 2018
H.R.6, SUPPORT for Patients and Communities Act
S.1276, Cannabidiol Research Expansion Act
Marijuana and Cannabidiol Research Expansion Act
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2018
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 19, 2018.
Original Filing: 300948380.xml
Lobbying Issues
Provisions relating to NIH, and drug abuse and treatment, as follows:
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019
Public Law 115-141, Consolidated Appropriations Act, FY2018
Public Law 115-123, Bipartisan Budget Act of 2018
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019, provisions relating to NIH and drug abuse and treatment
Drug abuse research and treatment related issues:
H.R.1732, Synthetic Drug Control Act of 2017
H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA)
H.R.3391, Medical Marijuana Research Act of 2017
S.2004, Combating the Opioid Epidemic Act
S.1803, Marijuana Effective Drug Studies (MEDS) Act of 2017
S.2260, Opioids and STOP Pain Initiative Act
S.2004, Combating the Opioid Epidemic Act
H.R.5298, Modernizing Drug Enforcement Act of 2018
H.R.5311/S.2456, Comprehensive Addiction and Recovery Act or CARA 2.0 Act of 2018
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2017
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 22, 2018.
Original Filing: 300932338.xml
Lobbying Issues
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH, and drug abuse and treatment
H.R.3219, Defense, Military Construction, Veterans Affairs, Legislative Branch, and Energy and Water Development National Security Appropriations Act, FY2018, Make America Secure Appropriations Act, FY2018, provisions relating to drug abuse
Public Law 115-56, Continuing Appropriations Act, FY2018 and Supplemental Appropriations for Disaster Relief Requirements Act, FY2017, provisions relating to drug abuse
H.R.3354, Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, FY2018, provisions relating to drug abuse
Public Law 115-90, Making further continuing appropriations for fiscal year 2018, and for other purposes, Public Law 115-90, Making further continuing appropriations for fiscal year 2018, and for other purposes, provisions relating to drug abuse
Public Law 115-96, Further Additional Continuing Appropriations Act, FY2018, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.3219, Defense, Military Construction, Veterans Affairs, Legislative Branch, and Energy and Water Development National Security Appropriations Act, FY2018, Make America Secure Appropriations Act, FY2018, provisions relating drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH and drug abuse and treatment
Drug abuse research and treatment related issues:
H.R.1732, Synthetic Drug Control Act of 2017
H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA)
H.R.3391, Medical Marijuana Research Act of 2017
S.780, Responsibly Addressing the Marijuana Policy Gap Act of 2017
S.1276, Cannabidiol Research Expansion Act
S.2004, Combating the Opioid Epidemic Act
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2017
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Oct. 20, 2017.
Original Filing: 300911159.xml
Lobbying Issues
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH, and drug abuse and treatment
H.R.3219, Defense, Military Construction, Veterans Affairs, Legislative Branch, and Energy and Water Development National Security Appropriations Act, FY2018, Make America Secure Appropriations Act, FY2018, provisions relating to drug abuse
Public Law 115-56, Continuing Appropriations Act, FY2018 and Supplemental Appropriations for Disaster Relief Requirements Act, FY2017, provisions relating to drug abuse
H.R.3354, Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, FY2018, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.3219, Defense, Military Construction, Veterans Affairs, Legislative Branch, and Energy and Water Development National Security Appropriations Act, FY2018, Make America Secure Appropriations Act, FY2018, provisions relating drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH and drug abuse and treatment
Drug abuse research and treatment related issues:
H.R.1732, Synthetic Drug Control Act of 2017
H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA)
H.R.3391, Medical Marijuana Research Act of 2017
S.780, Responsibly Addressing the Marijuana Policy Gap Act of 2017
S.1276, Cannabidiol Research Expansion Act
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2017
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 20, 2017.
Original Filing: 300891793.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH, and drug abuse and treatment
Department of Defense Appropriations, FY2018, provisions relating to drug abuse
Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017, provisions relating to drug abuse and treatment
President Trump's 2018 Budget
Public Law 115-30, Making further continuing appropriations for fiscal year 2017, and for other purposes, provisions relating to NIH, and drug abuse and treatment
Public Law 115-31, Consolidated Appropriations Act, FY2017, provisions relating to NIH, and drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Provisions relating to drug abuse as follows:
Public Law 115-30, Making further continuing appropriations for fiscal year 2017, and for other purposes
Public Law 115-31, Consolidated Appropriations Act, FY2017
Department of Defense Appropriations, FY2018
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 115-30, Making further continuing appropriations for fiscal year 2017, and for other purposes, provisions relating to NIH, and drug abuse and treatment
Public Law 115-31, Consolidated Appropriations Act, FY2017, provisions relating to NIH, and drug abuse and treatment
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH and drug abuse and treatment
Public Law 114-255, H.R.6, 21st Century Cures Act, Implementation of medical research issues.
Drug abuse research and treatment related issues:
H.R.1732, Synthetic Drug Control Act of 2017
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016
Medical Marijuana Research Act
H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA)
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2017
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 19, 2017.
Original Filing: 300871511.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017 and FY2018, provisions relating to NIH and drug abuse and treatment
H.R.1301, Department of Defense Appropriations, FY2017, provisions relating to drug abuse
Department of Defense Appropriations, FY2018, provisions relating to drug abuse
Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017, provisions relating to drug abuse and treatment
President Trump's 2018 Budget Blueprint
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.1301, Department of Defense Appropriations, FY2017, provisions relating to drug abuse
Department of Defense Appropriations, FY2018, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017 and FY2018, provisions relating to NIH and drug abuse and treatment
Public Law 114-255, H.R.6, 21st Century Cures Act, Implementation of medical research issues.
Drug abuse research and treatment related issues:
H.R.1732, Synthetic Drug Control Act of 2017
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016
Medical Marijuana Research Act
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2016
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 20, 2017.
Original Filing: 300852727.xml
Lobbying Issues
H.R.5926/S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH and drug abuse and treatment
H.R.5293/S.3000, Department of Defense Appropriations, FY2017, provisions relating to drug abuse
Public Law 114-223, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2017, and Zika Response and Preparedness Act, provisions relating to drug abuse and treatment
Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017, provisions relating to drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5293/S.3000, Department of Defense Appropriations, FY2017, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5926/S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH and drug abuse and treatment
Biomedical innovation legislation (Senate draft)
H.R.6, 21st Century Cures Act, Medical research issues.
H.R.34, 21st Century Cures Act, Medical research issues.
Drug abuse research and treatment related issues:
H.R.3537, Synthetic Drug Control Act of 2015
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016
S.3224/H.R.5934, Dangerous Synthetic Drug Control Act of 2016
S.36/H.R.4229, Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2016
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Oct. 19, 2016.
Original Filing: 300831492.xml
Lobbying Issues
H.R.5926/S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH and drug abuse and treatment
H.R.5293/S.3000, Department of Defense Appropriations, FY2017, provisions relating to drug abuse
H.R.5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2017, and Zika Response and Preparedness Act, provisions relating to drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5293/S.3000, Department of Defense Appropriations, FY2017, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5926/S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH and drug abuse and treatment
Biomedical innovation legislation (Senate draft)
H.R.6, 21st Century Cures Act, Medical research issues.
Drug abuse research and treatment related issues:
H.R.3537, Synthetic Drug Control Act of 2015
H.R.2536/S.1455, Recovery Enhancement for Addiction Treatment Act TREAT Act
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016
S.2423/H.R.4447, Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act
S.3224/H.R.5934, Dangerous Synthetic Drug Control Act of 2016
S.36/H.R.4229, Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2016
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 19, 2016.
Original Filing: 300812783.xml
Lobbying Issues
S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH and drug abuse and treatment
H.R.5293/S.3000, Department of Defense Appropriations, FY2017, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5293/S.3000, Department of Defense Appropriations, FY2017, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH and drug abuse and treatment
H.R.6, 21st Century Cures Act, Medical research issues.
Drug abuse research and treatment related issues:
S. 2030, The Advancing Targeted Therapies for Rare Diseases Act of 2015
S. 1622, The FDA Device Accountability Act of 2015
S. 2014, Next Generation Researchers Act
S. 800, The Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act
S. 849, Advancing Research for Neurological Diseases Act of 2015
S. 2503, Preventing Superbugs and Protecting Patients Act
S. 2511, Improving Health Information Technology
S. 1878, The Advancing Hope Act of 2015
S. 1077, The Advancing Breakthrough Medical Devices for Patients Act of 2015
S. 1101, The Medical Electronic Data Technology Enhancement for Consumers Health Act
S. 2055, The Medical Countermeasures Innovation Act of 2015
S. 1767, The Combination Products Innovation Act of 2015
S. 1597, Patient Focused Impact Assessment Act of 2015
S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act
S. 2700, FDA and NIH Workforce Authorities Modernization Act
S. 185, Promise for Antibiotics and Therapeutics for Health Act
S. 2713, Advancing Precision Medicine Act of 2016
S. 2745, Advancing NIH Strategic Planning and Representation in Medical Research Act
S. 2742, Promoting Biomedical Research and Public Health for Patients Act
Opioid abuse legislation.
H.R.2872, Opioid Addiction Treatment Modernization Act
H.R.3537, Synthetic Drug Control Act of 2015
H.R.2536/S.1455, Recovery Enhancement for Addiction Treatment Act TREAT Act
H.R.2805, Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015
H.R.3014, Medical Controlled Substances Transportation Act of 2015
H.R.3716, Ensuring Terminated Providers are Removed from Medicaid and CHIP Act
H.R.3821, Medicaid DOC Act
H.R.2646, Helping Families in Mental Health Crisis Act of 2015
S.524, Comprehensive Addiction and Recovery Act of 2016
H.R.4396, Heroin and Prescription Drug Abuse Prevention and Reduction Act
S.2256, Co-Prescribing Saves Lives Act of 2015
S.480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
S.2680, Mental Health Reform Act of 2016
S.2687, Plan of Safe Care Improvement Act
S.2423/H.R.4447, Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act
S.1455/H.R.2536, Recovery Enhancement for Addiction Treatment Act (TREAT Act)
H.R.5046, Comprehensive Opioid Abuse Reduction Act of 2016
H.R.3680, Co-Prescribing to Reduce Overdoses Act of 2016
H.R.4981, Opioid Use Disorder Treatment Expansion and Modernization Act
H.R.3691, Improving Treatment for Pregnant and Postpartum Women Act of 2016
H.R.4586, Lali's Law
H.R.4976, Opioid Review Modernization Act of 2016
H.R.4599, Reducing Unused Medications Act of 2016
H.R.4969, John Thomas Decker Act of 2016
H.R.4641, To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes.
H.R.4978, NAS Healthy Babies Act
H.R.3691, Improving Treatment for Pregnant and Postpartum Women Act of 2016
H.R.4229/S.36, Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2016
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 19, 2016.
Original Filing: 300796468.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH and drug abuse and treatment
Department of Defense Appropriations, FY2017, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations, FY2017, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH and drug abuse and treatment
H.R.6, 21st Century Cures Act, Medical research issues.
Drug abuse research and treatment related issues:
S. 2030, The Advancing Targeted Therapies for Rare Diseases Act of 2015
S. 1622, The FDA Device Accountability Act of 2015
S. 2014, Next Generation Researchers Act
S. 800, The Enhancing the Stature and Visibility of Medical Rehabilitation Research at NIH Act
S. 849, Advancing Research for Neurological Diseases Act of 2015
S. 2503, Preventing Superbugs and Protecting Patients Act
S. 2511, Improving Health Information Technology
S. 1878, The Advancing Hope Act of 2015
S. 1077, The Advancing Breakthrough Medical Devices for Patients Act of 2015
S. 1101, The Medical Electronic Data Technology Enhancement for Consumers Health Act
S. 2055, The Medical Countermeasures Innovation Act of 2015
S. 1767, The Combination Products Innovation Act of 2015
S. 1597, Patient Focused Impact Assessment Act of 2015
S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act
S. 2700, FDA and NIH Workforce Authorities Modernization Act
S. 185, Promise for Antibiotics and Therapeutics for Health Act
S. 2713, Advancing Precision Medicine Act of 2016
S. 2745, Advancing NIH Strategic Planning and Representation in Medical Research Act
S. 2742, Promoting Biomedical Research and Public Health for Patients Act
Opioid abuse legislation.
H.R.2872, Opioid Addiction Treatment Modernization Act
H.R.3537, Synthetic Drug Control Act of 2015
H.R.2536/S.1455, Recovery Enhancement for Addiction Treatment Act TREAT Act
H.R.2805, Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015
H.R.3014, Medical Controlled Substances Transportation Act of 2015
H.R.3716, Ensuring Terminated Providers are Removed from Medicaid and CHIP Act
H.R.3821, Medicaid DOC Act
H.R.2646, Helping Families in Mental Health Crisis Act of 2015
S.524, Comprehensive Addiction and Recovery Act of 2016
H.R.4396, Heroin and Prescription Drug Abuse Prevention and Reduction Act
S.2256, Co-Prescribing Saves Lives Act of 2015
S.480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
S.2680, Mental Health Reform Act of 2016
S.2687, Plan of Safe Care Improvement Act
S.2423/H.R.4447, Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2015
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 19, 2016.
Original Filing: 300774516.xml
Lobbying Issues
H.R.3020/S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, provisions relating to NIH and drug abuse and treatment
H.R.2685/S.1558, Department of Defense Appropriations Act, FY2016, provisions relating to drug abuse and treatment
Public Law No: 114-53, Continuing Appropriations Act, FY2016, provisions relating to drug abuse and treatment
H.R.2250, Further Continuing Appropriations Act, FY2016, provisions relating to drug abuse and treatment
Public Law No. 114-113, Consolidated Appropriations Act, FY2016, provisions relating to drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.2685/S.1558, Department of Defense Appropriations, FY2016, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.3020/S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, provisions relating to NIH and drug abuse and treatment
H.R.6, 21st Century Cures Act, Medical research issues.
Opioid abuse legislation.
H.R.2872, Opioid Addiction Treatment Modernization Act, generally
H.R.3537, Synthetic Drug Control Act of 2015, generally
H.R.2536, Recovery Enhancement for Addiction Treatment Act TREAT Act, generally
H.R.2805, Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015, generally
H.R.3014, Medical Controlled Substances Transportation Act of 2015, generally
H.R.3716, Ensuring Terminated Providers are Removed from Medicaid and CHIP Act, generally
H.R.3821, Medicaid DOC Act, generally
H.R.2646, Helping Families in Mental Health Crisis Act of 2015, generally
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2015
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Oct. 17, 2015.
Original Filing: 300755925.xml
Lobbying Issues
H.R.3020/S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, provisions relating to NIH and drug abuse and treatment
H.R.2685/S.1558, Department of Defense Appropriations Act, FY2016, provisions relating to drug abuse and treatment
Public Law No: 114-53, Continuing Appropriations Act, FY2016, Provisions relating to occupational health and safety issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.2685/S.1558, Department of Defense Appropriations, FY2016, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.3020/S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, provisions relating to NIH and drug abuse and treatment
H.R.6, 21st Century Cures Act, Medical research issues.
Opioid abuse legislation.
H.R.2872, Opioid Addiction Treatment Modernization Act, generally
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2015
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 17, 2015.
Original Filing: 300737564.xml
Lobbying Issues
S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, provisions relating to NIH and drug abuse and treatment
H.R.2685/S.1558, Department of Defense Appropriations Act, FY2016, provisions relating to drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.2685/S.1558, Department of Defense Appropriations, FY2016, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, provisions relating to NIH and drug abuse and treatment
H.R.6, 21st Century Cures Act, Medical research issues.
Opioid abuse legislation.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2015
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 17, 2015.
Original Filing: 300717911.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, provisions relating to NIH and drug abuse and treatment
Department of Defense Appropriations Act, FY2016, provisions relating to drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations, FY2016, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, provisions relating to NIH and drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2014
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 19, 2015.
Original Filing: 300700530.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, provisions relating to NIH and drug abuse and treatment
H.R.4870, Department of Defense Appropriations Act, FY2015, provisions relating to drug abuse and treatment
Public Law 113-164, Continuing Appropriations Resolution, FY2015, provisions relating to drug abuse and treatment
Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015, provisions relating to drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4870, Department of Defense Appropriations, FY2015, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, provisions relating to NIH and drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Oct. 16, 2014.
Original Filing: 300677395.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, provisions relating to NIH and drug abuse and treatment
H.R.4870, Department of Defense Appropriations Act, FY2015, provisions relating to drug abuse and treatment
Public Law 113-164, Continuing Appropriations Resolution, FY2015, provisions relating to drug abuse and treatment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4870, Department of Defense Appropriations, FY2015, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, provisions relating to NIH and drug abuse and treatment
S.264, Excellence in Mental Health Act, provisions relating to NIH and drug abuse
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 16, 2014.
Original Filing: 300657647.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, provisions relating to NIH and drug abuse
H.R.4870, Department of Defense Appropriations Act, FY2015, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4870, Department of Defense Appropriations, FY2015, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, provisions relating to NIH and drug abuse
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 18, 2014.
Original Filing: 300640536.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, provisions relating to NIH and drug abuse
Department of Defense Appropriations, FY2015, provisions relating to drug abuse
Public Law 113-46, Continuing Appropriations Act, FY2014, generally
Public Law 113-73, Making further continuing appropriations for fiscal year 2014, and for other purposes, generally
Public Law 113-76, Consolidated Appropriations Act, FY2014, generally
#17 below: National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations, FY2015, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, provisions relating to NIH and drug abuse
#17. National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 17, 2014.
Original Filing: 300617334.xml
Lobbying Issues
S.1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, provisions relating to NIH and drug abuse
H.R.2397/S.1429, Department of Defense Appropriations, FY2014, provisions relating to drug abuse
H.J.Res.59, Continuing Appropriations Resolution, FY2014, generally
Public Law 113-46, Continuing Appropriations Act, FY2014, generally
#17 below: National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.2397/S.1429, Department of Defense Appropriations, FY2014, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, provisions relating to NIH and drug abuse
#17. National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Oct. 19, 2013.
Original Filing: 300601085.xml
Lobbying Issues
S.1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, provisions relating to NIH and drug abuse
H.R.2397/S.1429, Department of Defense Appropriations, FY2014, provisions relating to drug abuse
H.J.Res.59, Continuing Appropriations Resolution, 2014, generally
#17 below: National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.2397/S.1429, Department of Defense Appropriations, FY2014, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, provisions relating to NIH and drug abuse
#17. National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 18, 2013.
Original Filing: 300574977.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, provisions relating to NIH and drug abuse
H.R.2397, Department of Defense Appropriations, FY2014, provisions relating to drug abuse
#17 below: National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.2397, Department of Defense Appropriations, FY2014, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, provisions relating to NIH and drug abuse
#17. National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 20, 2013.
Original Filing: 300558082.xml
Lobbying Issues
H.R.5856, Department of Defense Appropriations, FY2013, provisions relating to drug abuse
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH and drug abuse
Monitor Public Law 112-25, Budget Control Act of 2011, provisions relating to drug abuse
Public Law 112-175, Continuing Appropriations Resolution Act, FY2013, provisions relating to drug abuse.
Public Law 113-6, Consolidated and Further Continuing Appropriations Act, FY2013, provisions relating to drug abuse.
Public Law 112-240, American Taxpayer Relief Act of 2012, provisions relating to drug abuse.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, provisions relating to NIH and drug abuse
Monitor the following:
H.Con.Res.25,Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 (House Concurrent Resolution)
S.Con.Res.8, An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023 (Senate Concurrent Resolution)
Department of Defense Appropriations, FY2014, provisions relating to drug abuse
#17 below: National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5856, Department of Defense Appropriations, FY2013, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH and drug abuse
#17. National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 21, 2013.
Original Filing: 300536910.xml
Lobbying Issues
H.R.5856, Department of Defense Appropriations, FY2013, provisions relating to drug abuse
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH and drug abuse
#17 below: National Institute on Drug Abuse (NIDA)Monitor Public Law 112-25, Budget Control Act of 2011, provisions relating to drug abuse
H.J.Res.117, Continuing Appropriations Resolution, FY2013, provisions relating to drug abuse.
H.R. 8, American Taxpayer Relief Act of 2012, provisions relating to drug abuse.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5856, Department of Defense Appropriations, FY2013, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH and drug abuse
S.606/H.R.3059, Creating Hope Act of 2011, Incentives for medications development.
#17. National Institute on Drug Abuse (NIDA)Public Law 112-144, Food & Drug Administration Safety and Innovation Act, Incentives for medications development.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Oct. 17, 2012.
Original Filing: 300508144.xml
Lobbying Issues
H.R.5856, Department of Defense Appropriations, FY2013, provisions relating to drug abuse
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH and drug abuse
#17 below: National Institute on Drug Abuse (NIDA)Monitor Public Law 112-25, Budget Control Act of 2011, provisions relating to drug abuse
H.J.Res.117, Continuing Appropriations Resolution, FY2013, provisions relating to drug abuse.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5856, Department of Defense Appropriations, FY2013, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH and drug abuse
S.606/H.R.3059, Creating Hope Act of 2011, Incentives for medications development.
#17. National Institute on Drug Abuse (NIDA)Public Law 112-144, Food & Drug Administration Safety and Innovation Act, Incentives for medications development.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 16, 2012.
Original Filing: 300484435.xml
Lobbying Issues
H.R.5856, Department of Defense Appropriations, FY2013, provisions relating to drug abuse
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH and drug abuse
#17 below: National Institute on Drug Abuse (NIDA)Monitor Public Law 112-25, Budget Control Act of 2011, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5856, Department of Defense Appropriations, FY2013, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH and drug abuse
S.606/H.R.3059, Creating Hope Act of 2011, Incentives for medications development.
#17. National Institute on Drug Abuse (NIDA)S.3187, Food & Drug Administration Safety and Innovation Act, Incentives for medications development.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 19, 2012.
Original Filing: 300465063.xml
Lobbying Issues
Department of Defense Appropriations, FY2013, provisions relating to drug abuse
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH and drug abuse
#17 below: National Institute on Drug Abuse (NIDA)Monitor Public Law 112-25, Budget Control Act of 2011, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations, FY2013, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH and drug abuse
S.606/H.R.3059, Creating Hope Act of 2011, Incentives for medications development.
#17. National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 19, 2012.
Original Filing: 300442107.xml
Lobbying Issues
H.R.2219, Department of Defense Appropriations, FY2012, provisions relating to drug abuse
S.1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, provisions relating to NIH and drug abuse
#17 below: National Institute on Drug Abuse (NIDA)Monitor the following:
Public Law 112-33, Continuing Appropriations Act, 2012 (through 10/4/11)
Public Law 112-36, Continuing Appropriations Act, 2012 (through 11/18/11)
Public Law 112-67, 4th FY2012 Continuing Resolution (through December 17, 2011)
Public Law 112-68, 5th FY2012 Continuing Resolution (through December 23, 2011)
Public Law 112-25, Budget Control Act of 2011
Public Law 112-74, Consolidated Appropriations Act, FY2012, , provisions relating to drug abuse; provisions relating to NIH and drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.2219, Department of Defense Appropriations, FY2012, provisions relating to drug abuse
Public Law 112-74, Consolidated Appropriations Act, FY2012, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, provisions relating to NIH and drug abuse
Public Law 112-74, Consolidated Appropriations Act, FY2012, provisions relating to NIH and drug abuse
#17. National Institute on Drug Abuse (NIDA)S.606/H.R.3059, Creating Hope Act of 2011, Incentives for medications development.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on Oct. 18, 2011.
Original Filing: 300416245.xml
Lobbying Issues
H.R.2219, Department of Defense Appropriations, FY2012, provisions relating to drug abuse
S.1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, provisions relating to NIH and drug abuse
#17 below: National Institute on Drug Abuse (NIDA)Monitor the following:
H.R.2017, Continuing Appropriations Act, FY2012
H.R.2608, Continuing Appropriations Act, FY2012
Public Law 112-25, Budget Control Act of 2011
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.2219, Department of Defense Appropriations, FY2012, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, provisions relating to NIH and drug abuse
#17. National Institute on Drug Abuse (NIDA)S.606/H.R.3059, Creating Hope Act of 2011, Incentives for medications development.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 19, 2011.
Original Filing: 300394599.xml
Lobbying Issues
Department of Defense Appropriations, FY2012, provisions relating to drug abuse
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, provisions relating to NIH and drug abuse
#17 below: National Institute on Drug Abuse (NIDA)Public Law 112-8, Further Additional Continuing Appropriations Amendments, FY2011, provisions relating to drug abuse.
Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011, provisions relating to drug abuse.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations, FY2012, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, provisions relating to NIH and drug abuse
Medications development issues generally.
#17. National Institute on Drug Abuse (NIDA)S.606, Creating Hope Act of 2011, Incentives for medications development.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 19, 2011.
Original Filing: 300368785.xml
Lobbying Issues
Department of Defense Appropriations, FY2012, provisions relating to drug abuse
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, provisions relating to NIH and drug abuse
#17 below: National Institute on Drug Abuse (NIDA)Public Law 112-4, Further Continuing Appropriations Amendments, FY2011, provisions related to drug abuse
Public Law 112-6, Additional Continuing Appropriations Amendments, FY2011, provisions related to drug abuse
H.R.1/S.Amdt. 149, Full-Year Continuing Appropriations Act, FY2011, provisions related to drug abuse
Public Law 111-322, Continuing Appropriations and Surface Transportation Extensions Act, FY2011, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations, FY2012, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, provisions relating to NIH and drug abuse
Medications development issues generally
#17. National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Jan. 18, 2011.
Original Filing: 300340123.xml
Lobbying Issues
S.3800, Department of Defense Appropriations Act, FY2011, provisions relating to drug abuse
S.3686, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH and drug abuse
#17 below: National Institute on Drug Abuse (NIDA)Public Law 111-242, Continuing Appropriations Act, FY2011, Provisions relating to drug abuse
Public Law 111-290, Making further continuing appropriations for fiscal year 2011, and for other purposes, Provisions relating to drug abuse
Public Law 111-317, Making further continuing appropriations for fiscal year 2011, and for other purposes, Provisions relating to drug abuse
Public Law 111-322, Continuing Appropriations and Surface Transportation Extensions Act, FY2011, Provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.3800, Department of Defense Appropriations Act, FY2011, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.914, Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009; NIH & Medications development.
#17. National Institute on Drug Abuse (NIDA)S.3686, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2011, provisions relating to NIH and drug abuse.
Public Law 111-148, Patient Protection and Affordable Care Act, Drug abuse related issues
Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Druge abuse related issues
S.3694/H.R.1326, Great Ape Protection Act of 2010, Drug abuse related issues
Medications Development issues generally
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2010
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on Oct. 19, 2010.
Original Filing: 300317397.xml
Lobbying Issues
S.3800, Department of Defense Appropriations Act, FY2011, provisions relating to drug abuse
S.3686, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH and drug abuse
#17 below: National Institute on Drug Abuse (NIDA)H.R.3081, Continuing Appropriations Act, FY2011, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.3800, Department of Defense Appropriations Act, FY2011, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.914, Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009; NIH & Medications development.
#17. National Institute on Drug Abuse (NIDA)S.3686, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2011, provisions relating to NIH and drug abuse.
Public Law 111-148, Patient Protection and Affordable Care Act, Drug abuse related issues
Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Druge abuse related issues
Medications Development issues generally
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2010
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 16, 2010.
Original Filing: 300288266.xml
Lobbying Issues
Department of Defense Appropriations Act, FY2011, provisions relating to drug abuse
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH and drug abuse
#17 below: National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations Act, FY2011, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.914, Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009; NIH & Medications development.
#17. National Institute on Drug Abuse (NIDA)Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2011, provisions relating to NIH and drug abuse.
America's Healthy Futures Act of 2009, Drug Abuse related issues.
H.R.3200, America's Affordable Health Choices Act of 2009, Drug abuse related issues.
S.1679, Affordable Health Choices Act, Drug abuse related issues.
H.R.3962, Affordable Health Care for America Act, Drug abuse related issues
Public Law 111-148, Patient Protection and Affordable Care Act, Drug abuse related issues
Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Druge abuse related issues
Medications Development issues generally
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2010
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 19, 2010.
Original Filing: 300262339.xml
Lobbying Issues
Department of Defense Appropriations Act, FY2011, provisions relating to drug abuse
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH and drug abuse
#17 below: National Institute on Drug Abuse (NIDA)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations Act, FY2011, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.914, Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009; NIH & Medications development.
#17. National Institute on Drug Abuse (NIDA)Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2011, provisions relating to NIH and drug abuse.
America's Healthy Futures Act of 2009, Drug Abuse related issues.
H.R.3200, America's Affordable Health Choices Act of 2009, Drug abuse related issues.
S.1679, Affordable Health Choices Act, Drug abuse related issues.
H.R.3962, Affordable Health Care for America Act, Drug abuse related issues
Public Law 111-148, Patient Protection and Affordable Care Act, Drug abuse related issues
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on Jan. 18, 2010.
Original Filing: 300234093.xml
Lobbying Issues
Public Law 111-5, American Recovery and Reinvestment Act of 2009; provisions relating to NIH and drug abuse
H.R.3326, Department of Defense Appropriations Act, FY2010, provisions relating to drug abuse
#17. National Institute on Drug Abuse (NIDA)H.R.3293, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH and drug abuse
H.R.2918, Legislative Branch Appropriations Act, FY2010, Division B Continuing Appropriations Resolution, provisions relating to NIH and drug abuse
H.R.2996, Department of the Interior, Environment, and Related Agencies Appropriations Act, FY2010, Division B is the
Further Continuing Appropriations Resolution, FY2010, provisions relating to NIH and drug abuse
H.R.3288, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, FY2010, the
Consolidated Appropriations Act, FY2010, provisions relating to NIH and drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.3326, Department of Defense Appropriations Act, FY2010, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 111-5, American Recovery and Reinvestment Act of 2009; provisions relating to NIH and drug abuse
S.914, Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009; NIH & Medications development.
#17. National Institute on Drug Abuse (NIDA)H.R.3293, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH and drug abuse
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on Oct. 16, 2009.
Original Filing: 300206698.xml
Lobbying Issues
Public Law 111-5, American Recovery and Reinvestment Act of 2009; provisions relating to NIH and drug abuse
H.R.3326, Department of Defense Appropriations Act, FY2010, provisions relating to drug abuse
#17. National Institute on Drug Abuse (NIDA)H.R.3293, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH and drug abuse
H.R.2918, Legislative Branch Appropriations Act, FY2010, Division B Continuing Appropriations Resolution, provisions relating to NIH and drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.3326, Department of Defense Appropriations Act, FY2010, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 111-5, American Recovery and Reinvestment Act of 2009; provisions relating to NIH and drug abuse
S.914, Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009; NIH & Medications development.
#17. National Institute on Drug Abuse (NIDA)H.R.3293, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH and drug abuse
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $20,000. The report was filed on July 15, 2009.
Original Filing: 300177387.xml
Lobbying Issues
Public Law 111-5, American Recovery and Reinvestment Act of 2009; provisions relating to NIH and drug abuse
Department of Defense Appropriations Act, FY2010, provisions relating to drug abuse
#17. National Institute on Drug Abuse (NIDA)Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH and drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations Act, FY2010, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 111-5, American Recovery and Reinvestment Act of 2009; provisions relating to NIH and drug abuse
S.914, Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009; NIH & Medications development.
#17. National Institute on Drug Abuse (NIDA)Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH and drug abuse
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, Van Scoyoc Associates lobbied for College on Problems of Drug Dependence , earning $10,000. The report was filed on April 12, 2009.
Original Filing: 300146311.xml
Lobbying Issues
H.R. 1, American Recovery and Reinvestment Act of 2009; provisions relating to NIH and drug abuse
H.R. 1105, Omnibus Appropriations Act, FY2009; provisions relating to NIH and drug abuse
Department of Defense Appropriations Act, FY2010, provisions relating to drug abuse
#17. National Institute on Drug Abuse (NIDA)Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH and drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations Act, FY2010, provisions relating to drug abuse
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1, American Recovery and Reinvestment Act of 2009; provisions relating to NIH and drug abuse
H.R. 1105, Omnibus Appropriations Act, FY2009; provisions relating to NIH and drug abuse
#17. National Institute on Drug Abuse (NIDA)Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH and drug abuse
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
Van Scoyoc Associates filed a lobbying registration on Feb. 9, 2009 to represent College on Problems of Drug Dependence, effective Jan. 8, 2009.
Original Filing: 300137526.xml
Issue(s) they said they’d lobby about: Appropriations and authorization regarding drug abuse research and related issues. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...